D.E. Shaw & Co’s Global Blood Therapeutics, Inc. GBT Stock Holding History

D.E. Shaw & Co’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,000	Closed	-$433K	–	4621
2020 Q4	$433K	Hold	10,000	–	–	﹤0.01%	3453
2020 Q3	$551K	Hold	10,000	–	–	﹤0.01%	3182
2020 Q2	$631K	Sell	10,000 -10,000	-50%	-$686K	﹤0.01%	3206
2020 Q1	$1.02M	Sell	20,000 -10,100	-34%	-$677K	﹤0.01%	2711
2019 Q4	$2.39M	Buy	30,100 +20,000	+198%	+$1.19M	﹤0.01%	2324
2019 Q3	$490K	Hold	10,100	–	–	﹤0.01%	3226
2019 Q2	$531K	Hold	10,100	–	–	﹤0.01%	3050
2019 Q1	$535K	Hold	10,100	–	–	﹤0.01%	2974
2018 Q4	$415K	Buy	+10,100	New	+$378K	﹤0.01%	3193

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

D.E. Shaw & Co's GBT Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 279,400 shares — an estimated $19M sold.

D.E. Shaw & Co first reported a position in GBT in Q1 2016 and held it in 20 quarters. The position peaked at $19M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

D.E. Shaw & Co reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
D.E. Shaw & Co sold 279,400 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $19M.
D.E. Shaw & Co first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 20 quarters.
D.E. Shaw & Co's Global Blood Therapeutics, Inc. position peaked at $19M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.